Resource Library

Discover Kymera’s research and resources on our exciting platform, pipeline, and additional cutting-edge technologies.

  • Programs & Targets

  • Indications

  • Year

  • Resource Type/Format

  • Development Stage

Related Resources

June 18, 2019

IRAK4 degraders for MYD88 mutant lymphoma

International Conference on Malignant Lymphoma (ICML)
MYD88 Tumors
Read More
March 29, 2019

KYM-001, first-in-class oral IRAK4 protein degraders, induce tumor regression in a xenograft model of MYD-88 mutant ABC DLBCL alone and in combination with BTK inhibition

American Association for Cancer Research (AACR) Annual Meeting
MYD88 Tumors
Read More
December 1, 2018

Targeted degradation of IRAK4 protein via heterobifunctional small molecules for treatment of MYD88 mutant lymphoma

American Society of Hematology (ASH) Annual Meeting
MYD88 Tumors
Read More